Cystic Fibrosis Newborn Screening: Cost Trajectory as a Marker to Improve Health Outcomes. Shenoy A, Southern K. Pediatr Pulmonol 2026;61:e71747.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shenoy A, Southern K. Cystic Fibrosis Newborn Screening: Cost Trajectory as a Marker to Improve Health Outcomes. Pediatr Pulmonol 2026;61:e71747.
PMID: 42472368